Cancer clinical trials in the region Pays de la Loire
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Lung cancer
#NCT03774732
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Locally Advanced
Metastatic
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
EGFR
ALK
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut Sainte Catherine (Avignon), Institut Bergonié (Bordeaux), Centre François Baclesse (Caen ), Centre Hospitalier du docteur Jean Eric Techer (Calais) (and 26 more...)
UNICANCER
Phase 3
Lymphoma
#NCT06191744
B cell lymphoma
Follicular lymphoma
CD20
Systemic Treatment-Naive
None
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital Saint Louis AP-HP (Paris), Centre Hospitalier du Mans (Le Mans), CHU Caen Normandie (Caen), Centre Hospitalier d'Avignon (Avignon) (and 2 more...)
Genmab
Phase 3
Lymphoma
#NCT06091254
B cell lymphoma
Follicular lymphoma
CD20
Systemic Treatment-Naive
None
Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier d'Argenteuil (Argenteuil), Centre Hospitalier Régional Universitaire de Tours (Tours), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 2 more...)
Regeneron Pharmaceuticals
Phase 3
Breast cancer
#NCT05646862
HER2 Negative
HR Positive
Locally Advanced
Metastatic
PIK3CA
Targeted therapy
Hormone therapy
Centre Hospitalier de la Côte Basque (Bayonne), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre Léon Bérard (Lyon), Institut du cancer de Montpellier (Montpellier), IUCT Oncopôle (Toulouse) (and 2 more...)
Hoffmann-La Roche
Phase 3
Colon cancer
Rectal cancer
#NCT05078047
Adenocarcinoma
Metastatic
MSI/dMMR
Immunotherapy
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Henri-Mondor AP-HP (Créteil) (and 13 more...)
UNICANCER
Phase 3
Kidney cancer
#NCT05678673
Other
Locally Advanced
Metastatic
Systemic Treatment-Naive
CHU Reims (Reims), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital Henri-Mondor AP-HP (Créteil), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand) (and 7 more...)
Exélixis
Phase 3
Lung cancer
#NCT05984277
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Metastatic
Systemic Treatment-Naive
PDL1 Negative (< 1%)
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
EGFR
ALK
ROS-1
Institut Godinot (Reims), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre François Baclesse (Caen ) (and 8 more...)
AstraZeneca
Phase 3
Colon cancer
#NCT05855200
Adenocarcinoma
Localized
Locally Advanced
MSI/dMMR
Systemic Treatment-Naive
Systemic Treatment-Naive
MSS
Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez), Hôpital de la Timone AP-HM (Marseille), Centre Eugene Marquis (Rennes), Hôpital Foch (Suresnes), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon) (and 6 more...)
GlaxoSmithKline
Phase 3
Lung cancer
#NCT06077760
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Localized
Locally Advanced
Surgery
Surgery
Immunotherapy
Immunotherapy
CHU - Haut-lévêque - Bordeaux (Pessac), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Hôpital Cochin (Paris ), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier) (and 1 more...)
Merck Sharp & Dohme LLC
Phase 3
Kidney cancer
#NCT05219318
Clear cell carcinoma
Locally Advanced
Metastatic
Immunotherapy
Targeted therapy
0
1 or 2
CHU de St-Pierre (La Réunion), Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez), Centre Hospitalier Universitaire Dupuytren (Limoges), Institut Paoli-Calmettes (Marseille), Centre Hospitalier Universitaire de Bordeaux (Bordeaux) (and 22 more...)
CHU de Bordeaux